Management of unresectable hilar bile duct cancer - Preoperative diagnosis, treatment selection, and clinical outcome

Hepato-Gastroenterology

Volumn 50, Issue 51, 2003, Pages 614-620

  Hirai, Ichiro ^a,b   Kimura, Wataru ^a   Fuse, Akira ^a   Suto, Koichi ^a   Sakurai, Fumiaki ^a   Shibasaki, Hiroyuki ^a  

^a YAMAGATA UNIVERSITY   (Japan)

^b YAMAGATA UNIVERSITY   (Japan)

Author keywords

Clinical outcome; Conservative therapy; Expandable metallic stent; Hilar bile duct cancer

Indexed keywords

BILIRUBIN; METAL;

ADULT; AGED; ARTICLE; BILE DUCT CANCER; BILIRUBIN BLOOD LEVEL; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER INVASION; CANCER SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; LAPAROTOMY; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; METASTASIS; PORTAL VEIN; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; STENT; SURVIVAL RATE; TREATMENT INDICATION; TREATMENT OUTCOME;

AGED; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; BILIRUBIN; CHOLANGIOGRAPHY; CHOLESTASIS, INTRAHEPATIC; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PALLIATIVE CARE; PATIENT SELECTION; RADIOTHERAPY, ADJUVANT; STENTS; SURVIVAL RATE;

EID: 0038239591     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Parc Y, Frileux P, Balladur P, Delva E, Hannoun L, Parc R: Surgical strategy for the management of hilar bile duct cancer. Br J Surg 1997; 84:1675-1679.
2. Iwatsuki S, Todo S, Marsh JW, Madariaga JR, Lee RG, Dvorchik I, Fung JJ, Starzl TE: Treatment of hilar cholangiocarcinoma (Klatskin tumors) with hepatic resection or transplantation. J Am Coll Surg 1998; 187:358-364.
3. Gerhards MF, van Gulik TM, de Wit LT, Obertop H, Gouma DJ: Evaluation of morbidity and mortality after resection for hilar cholangiocarcinoma-a single center experience. Surgery 2000; 127:395-404.
4. LaBerge JM, Doherty M, Gordon RL, Ring EJ: Hilar malignancy: treatment with an expandable metallic transhepatic biliary stent. Radiology 1990; 170:793-797.
5. Coons H: Metallic stents for the treatment of biliary obstruction: a report of 100 cases. Cardiovasc Intervent Radiol 1992; 15:367-374.
6. Salomonowitz EK: Adam A, Antonucci F, Stuckmann G, Zollikofer CL: Malignant biliary obstruction: treatment with self-expandable stainless steel endoprosthesis. Cardiovasc Intervent Radiol 1992; 15:351-355.
7. Stoker J, Lameris JS, van Blankenstein M: Percutaneous metallic self-expandable endoprostheses in malignant hilar biliary obstruction. Gastrointest Endosc 1993; 39:43-49.
8. Banerjee B, Teplick SK: Nonsurgical management of primary cholangiocarcinoma. retrospective analysis of 40 cases. Dig Dis Sci 1995; 40:701-705.
9. Lee BH, Choe DH, Lee JH, Kim KH, Chin SY: Metallic stents in malignant biliary obstruction: prospective long-term clinical results. AJR 1997; 168:741-745.
10. Kaiho T, Miyazaki M, Ito H, Makagawa K, Ambiru S, Shimizu H, Shimizu Y, Okuno A, Nozawa S, Nukui Y, Nakajima N: Treatment of unresectable hepatic hilar malignancies with self-expanding metallic stents. Hepatogastroenterology 1999; 46:2781-2790.
11. Bismuth H, Corlette MB: Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. Surg Gynecol Obstet 1975; 140:170-178.
12. Engels JT, Balfe DM, Lee JK: Biliary carcinoma: CT evaluation of extrahepatic spread. Radiology 1989; 172:35-40.
13. International Union Against Cancer (UICC): TNM classification of malignant tumors. 5th Edition. New York: Wiley-Liss; 1997.
14. Nakeeb A, Pitt HA, Sohn TA, Coleman J, Abrams RA, Piantadosi S, Hruban RH, Lillemoe KD, Yeo CJ, Cameron JL: Cholangiocarcinoma A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg 1996; 224:463-475.
15. Su CH, Tsay SH, Wu CC, Shyr YM, King KL, Lee CH, Lui WY, Liu TJ, P'eng FK: Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma. Ann Surg 1996; 223:384-394.
16. Burke EC, Jarnagin WR, Hochwald SN, Pisters PW, Fong Y, Blumgart LH: Hilar cholangiocarcinoma-patters of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system. Ann Surg 1998; 228:385-394.
17. Neuhaus P, Jonas S, Bechstein WO, Lohmann R, Radke C, Kling N, Wex C, Lobeck H, Hintze R: Extended resections for hilar cholangiocarcinoma. Ann Surg 1999; 230:808-819.
18. Tsao JI, Nimura Y, Kamiya J, Hayakawa N, Kondo S, Nagino M, Miyachi M, Kanai M, Uesaka K, Oda K, Rossi RL, Braasch JW, Dugan JM: Management of hilar cholangiocarcinoma-comparison of an American and a Japanese experience. Ann Surg 2000; 232:166-174.
19. Hann LE, Fong Y, Shriver CD, Botet JF, Brown KT, Klimstra DS, Blumgart LH: Malignant hepatic hilar tumors: can ultrasonography be used as an alternative to angiography with CT arterial portography for determination of resectability? J Ultrasound Med 1996; 15:37-45.
20. Nishio H, Kamiya J, Nagino M, Kanai M, Uesaka K, Sakamoto E, Fukatsu T, Nimura Y: Value of percutaneous transhepatic portography before hepatectomy for hilar cholangiocarcinoma. Br J Surg 1999; 86:1415-1421.
21. Feydy A, Vilgrain V, Denys A, Sibert A, Belghiti J, Vullierme MP, Menu Y: Helical CT assessment in hilar cholangiocarcinoma: correlation with surgical and pathologic findings. AJR 1999; 172:73-77.
22. Small WC, Mehard WB, Langmo LS, Dagher AP, Fishman EK, Heiken JP, Bernardino ME: Preoperative determination of the resectability of hepatic tumors: efficacy of CT during arterial portography. AJR 1993; 161:319-322.
23. Soyer P, Bluemke DA, Fishman EK: CT during arterial portography for the preoperative evaluation of hepatic tumors: how, when, and why? AJR 1994; 163:1325-1331.
24. Lameris JS, Stoker J, Nijs HG, Zonderland HM, Terpstra OT, van Blankenstein M, Schutte HE: Malignant biliary obstruction: percutaneous use of self-expandable stents. Radiology 1991; 179:703-707.
25. Clouse ME, Evans D, Costello P, Alday M, Edwards SA, McDermott WV Jr: Percutaneous transhepatic biliary drainage. Ann Surg 1983; 198:25-29.
26. Ede RJ, Williams SJ, Hatfield AR, McIntyre S, Mair G: Endoscopic management of inoperable cholangiocarcinoma using iridium-192. Br J Surg 1989; 76:867-869.
27. Cameron JL, Pitt HA, Zinner MJ, Kaufman SL, Coleman J: Management of proximal cholangiocarcinomas by surgical resection and radiotherapy. Am J Surg 1990; 159:91-98.
28. Ohnishi H, Asada M, Shichijo Y, Iijima N, Itobayashi E, Shimura K, Suzuki T, Yoshida S, Mine T: External radiotherapy for biliary decompression of hilar cholangiocarcinoma. Hepatogastroenterology 1995; 42:265-268.
29. Kuvshinoff BW, Armstrong JG, Fong Y, Schupak K, Getradjman G, Heffernan N, Blumgart LH: Palliation of irresectable hilar cholangiocarcinoma with biliary drainage and radiotherapy. Br J Surg 1995; 82:1522-1525.